Mouwasat says benefited from lower financing costs, expects Jeddah hospital opening this year

Khalid Alsaleem, Managing Director of Mouwasat Medical Services Co.

Khalid Alsaleem, Managing Director of Mouwasat Medical Services Co., said the company benefited from lower financing costs, reduced provisions for receivables impairments, and collections on prior-year balances, as reported in Q3 2025.

In an interview with Argaam, Alsaleem added that Q4 2025 net profit growth continues the positive trend from the first nine months of 2025 compared with 2024.

He noted that the inpatient segment saw notable occupancy growth, driven by expanding subspecialties and diverse medical expertise across all hospitals, significantly boosting 2025 revenues.

On expansion, Alsaleem said the company is pursuing horizontal and vertical growth, with five projects under construction in 2025, Yanbu Hospital opened in February 2026, and Jeddah Hospital is expected to open later this year; the official date is to be announced.

The company aims to sustain revenue growth in 2026 by expanding clinics and medical specialties across its hospitals, meeting rising healthcare demand.

According to Argaam data, Mouwasat’s profits rose to SAR 822 million in 2025 from SAR 645.8 million in 2024, with Q4 earnings of SAR 238.4 million.